Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06903676 · ClinicalTrials.gov registry record · NA

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

A NA study of Pancreatitis and Pancreatectomy, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06903676 is a NA study of Pancreatitis and Pancreatectomy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 50 participants, below the 619-participant average among 17 other Pancreatitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06903676, a NA study of Pancreatitis and Pancreatectomy, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.

Interventions

  • DEVICE TRP-2 Urine Dipstick

Study Locations (1)

Indiana

  • Indiana University Health University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-08-05
Est. Completion 2026-04
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06903676

The ClinicalTrials.gov registry entry for NCT06903676 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 619-participant average among 17 other Pancreatitis trials with a reported enrollment target (92% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which TRP-2 Urine Dipstick is the first listed.

NCT06903676 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06903676 about?

NCT06903676 is a clinical study titled "Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)". The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.

What is the current status of trial NCT06903676?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-05. Estimated completion is 2026-04.

What conditions does trial NCT06903676 study?

This clinical trial studies the following conditions: Pancreatitis, Pancreatectomy.

What interventions are being tested in trial NCT06903676?

The interventions under investigation include: TRP-2 Urine Dipstick (DEVICE).

Who is sponsoring clinical trial NCT06903676?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06903676 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.